Melchionda, Nazario

Nonalcoholic Fatty Liver Disease

Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2,581

Metformin in non-alcoholic steatohepatitis.

Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 682

Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries

Pasquali, R., Fabbri, R., Venturoli, S., Paradisi, R., Antenucci, D., & Melchionda, N. (1986) · American Journal of Obstetrics and Gynecology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 92

Physical activity monitoring in obese people in the real life environment

Benedetti, M. G., Di Gioia, A., Conti, L., Berti, L., Esposti, L. D., Tarrini, G., Melchionda, N., & Giannini, S. (2009) · Journal of NeuroEngineering and Rehabilitation

Physical Activity and HealthContext-Aware Activity Recognition Systems

Cited by 44